{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:42:08Z","timestamp":1776292928673,"version":"3.50.1"},"reference-count":22,"publisher":"Media Sphere Publishing House","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2023,10,5]]},"abstract":"<jats:p>Objective. To assess the severity of anxiety, depression, insomnia and asthenia in patients with episodic migraine and tension-type headache before and after treatment. Material and methods. 104 patients aged 18 to 74 years were examined. Patients were divided into two groups: the 1st \u2014 41 patients diagnosed with episodic migraine, the 2nd \u2014 63 patients with episodic tension-type headache. The intensity of headache was assessed using the visual analog scale (VAS). The Hospital Anxiety and Depression Scale (HADS), the Levin questionnaire, and the Multidimensional Fatigue Inventory scale (MFI-20) were used to identify comorbid affective pathology, insomnia, and asthenia, respectively. Results. Headache severity according to VAS in the 1st group was higher (5.8\u00b11.3 points) than in 2nd (3.8\u00b11.2 points). Clinical anxiety was detected in 66.3% of patients without statistically significant differences between groups. The mean HADS anxiety score was 13.9\u00b13.5 in 1st group, 12.7\u00b13.7 \u2014 in 2nd. Clinical depression was detected in 45.2% of patients, more often in the 2nd group \u2014 50.8% than in the 1st (36.6%). The mean depression score according to HADS was 9.0\u00b14.4 and 9.7\u00b13.6 in the 1st and 2nd groups respectively. The intensity of headache was statistically significantly higher in patients with clinical anxiety. Both groups were found to have insomnia and asthenia. The majority of patients \u2014 67.3% had myofascial pain syndrome. When re-evaluating the severity of disorders after treatment (using anxiolytics, antidepressants, muscle relaxants, magnesium and neurometabolics), a significant positive trend was noted. Reducing the intensity of headaches to 3.2\u00b10.9 points (according to VAS scale) was in patients with migraine and 1.9\u00b10.8 points in 2nd group. Relief of anxiety and depressive disorders was observed (HADS) in 1st (4.3\u00b13.9) and 2nd (4.5\u00b13.3) groups, the severity of depression (HADS) \u2014 2.1\u00b12.2 in 1st and 2.8\u00b13.2 in 2nd groups, as well as a decrease in asthenia and normalization of sleep. The decrease in the severity of asthenia during treatment was more significant in patients treated with Cytoflavin. Conclusion. Identification and treatment of comorbid pathology leads to positive results in the treatment of primary headaches such as episodic migraine and TTH.<\/jats:p>","DOI":"10.17116\/jnevro202312309152","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T13:41:14Z","timestamp":1696513274000},"page":"52","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic approaches to comorbid pathology in episodic migraine and tension-type headache"],"prefix":"10.17116","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9392-1789","authenticated-orcid":false,"given":"L.M.","family":"Mirzaeva","sequence":"first","affiliation":[{"name":"Mechnikov North-Western State Medical University","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-6822","authenticated-orcid":false,"given":"A.S.","family":"Lobzina","sequence":"additional","affiliation":[{"name":"Mechnikov North-Western State Medical University","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0302-6694","authenticated-orcid":false,"given":"K.N.","family":"Akhmedova","sequence":"additional","affiliation":[{"name":"Mechnikov North-Western State Medical University","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7657-8181","authenticated-orcid":false,"given":"G.I.","family":"Shvartsman","sequence":"additional","affiliation":[{"name":"Mechnikov North-Western State Medical University","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-4858","authenticated-orcid":false,"given":"I.I.","family":"Kula","sequence":"additional","affiliation":[{"name":"Mechnikov North-Western State Medical University","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-3695","authenticated-orcid":false,"given":"T.G.","family":"Vstavskaia","sequence":"additional","affiliation":[{"name":"Mechnikov North-Western State Medical University","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9031-0376","authenticated-orcid":false,"given":"E.M.","family":"Pervova","sequence":"additional","affiliation":[{"name":"LLC \u00abAVA-PETER\u00bb","place":["Saint Petersburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202312309152-1","doi-asserted-by":"publisher","DOI":"10.21518\/2079-701X-2021-2-94-100"},{"key":"key-10.17116\/jnevro202312309152-2","unstructured":"Tabeeva GR, Osipova VV. Pervichnye golovnye boli: diagnostika, klinika, terapiya. Prakticheskoe rukovodstvo. M.: OOO \u00abMeditsinskoe informatsionnoe agentstvo\u00bb; 2014. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-3","unstructured":"Selitskii GV, Stulin ID, Sorokina ND, et al. Pervichnaya golovnaya bol\u2019. Uchebnoe posobie. M. 2015. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-4","unstructured":"Tabeeva GR, Yakhno NN. Migren\u2019. M.: GEOTAR-Media; 2011. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-5","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2017117214-9"},{"key":"key-10.17116\/jnevro202312309152-6","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413485658"},{"key":"key-10.17116\/jnevro202312309152-7","unstructured":"Kachetova EN. Otsenka urovnya trevogi u patsientov s khronicheskoi golovnoi bol\u2019yu napryazheniya. Meditsinskii Alfavit. 2018;1(1):65-65. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-8","doi-asserted-by":"publisher","DOI":"10.25731\/RASP.2018.03.024"},{"key":"key-10.17116\/jnevro202312309152-9","unstructured":"Tabeeva GR. Golovnaya bol\u2019: rukovodstvo dlya vrachei. M.: GEOTAR-Media; 2014. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-10","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2013-2332"},{"key":"key-10.17116\/jnevro202312309152-11","unstructured":"Evdokimova EM, Tabeeva GR. Bessonnitsa u bol\u2019nykh migren\u2019yu. Rossiiskii Zhurnal Boli. 2017;(1):17-20. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-12","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32832b2387"},{"key":"key-10.17116\/jnevro202312309152-13","doi-asserted-by":"crossref","unstructured":"Osipova VV. Pericranial muscle dysfunction in primary headache and its correction. Neurology, Neuropsychiatry, Psychosomatics. 2010;4(9):29-36. (In Russ.)","DOI":"10.14412\/2074-2711-2010-113"},{"key":"key-10.17116\/jnevro202312309152-14","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-012-0479-9"},{"key":"key-10.17116\/jnevro202312309152-15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.09.010"},{"key":"key-10.17116\/jnevro202312309152-16","doi-asserted-by":"publisher","DOI":"10.1111\/head.12521"},{"key":"key-10.17116\/jnevro202312309152-17","unstructured":"Serafini G, Pompili M, Innamorati M, et al. Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci. 2012;16(10):1389-1398"},{"key":"key-10.17116\/jnevro202312309152-18","unstructured":"Zakharov VV, Gromova DO. Comorbid anxiety disorders in neurological patients: approaches to therapy. Behavioral Neurology. 2023;(1):9-13. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-19","unstructured":"Skoromets AA, Pugacheva EL. Efficacy of the complex drug cytoflavin in the treatment of consequences of mild brain injury. Poliklinika. 2011;5:50-55. (In Russ.)"},{"key":"key-10.17116\/jnevro202312309152-20","doi-asserted-by":"publisher","DOI":"10.32364\/2587-6821-2020-4-9-590-594"},{"key":"key-10.17116\/jnevro202312309152-21","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2017117214-9"},{"key":"key-10.17116\/jnevro202312309152-22","unstructured":"Medvedeva LA, Zagorul\u2019ko OI, Shevtsova GE. Vliyanie trevogi i depressii na vyrazhennost\u2019 bolevogo sindroma u patsientov s khronicheskimi golovnymi bolyami. Rossiiskii Zhurnal Boli. 2017;(1):24-29. (In Russ.)"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:47:46Z","timestamp":1745488066000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2023\/9\/1199772982023091052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,10,5]]}},"alternative-id":["10.17116\/jnevro202312309152"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202312309152","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}